| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |